Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT07628257

Cerebral Connectivity and Metabolic Phenotype of Gliomas: Prospective Addition of DTI and Rs-fMRI to a Preoperative FDG PET Strategy, With Neuropsychological Correlates and Post-treatment Follow-up

Conditions: Glioblastoma

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 80
Sponsor: Centre Paul Strauss

Location: Institut public de cancérologie Strauss Europe Strasbourg

Summary

The aim of this study is to determine whether the diffuse cerebral metabolic disturbances observed in glioblastoma are exclusively linked to the direct and indirect effects of tumor infiltration (particularly structural disconnection), or whether they also reflect a more global alteration of neurometabolic and neurovascular coupling mechanisms. This approach thus aims to better understand the pathophysiological basis of cognitive impairment in glioblastoma and to characterize the impact of the disease at the level of brain networks.

Eligibility Criteria

Inclusion Criteria: * Adult patients * Patients with glioblastoma * Patients treated in the Nuclear Medicine \& Molecular Imaging Department of the Strauss Institute for PET/MRI scans for: * Preoperative metabolic evaluation of a brain-expanding lesion Exclusion Criteria: * Contraindications to MRI * Minor or incapacitated adult * Patient deprived of liberty * Patient under legal guardianship * Patient unable to consent * Pregnant or breastfeeding woman

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07628257). StuddyBuddy aggregates publicly available trial information.